Hikma pharmaceuticals shares
WebJan 18, 2024 · Vojta, who joined Hikma in October 2024, purchased the shares on Tuesday at an average price of 1,702.68p each, for a total value of £17,026.76. Earlier in January, Hikma Pharmaceuticals launched ... Web1 day ago · Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and ...
Hikma pharmaceuticals shares
Did you know?
WebApr 14, 2024 · 6 brokers have issued 12-month price targets for Hikma Pharmaceuticals' stock. Their HIK share price forecasts range from GBX 1,700 to GBX 2,100. On average, … WebApr 14, 2024 · In other Hikma Pharmaceuticals news, insider Deneen Vojta purchased 1,000 shares of the firm’s stock in a transaction on Tuesday, January 17th. The shares were purchased at an average price of GBX 1,703 ($21.09) per share, for a total transaction of £17,030 ($21,089.78). Corporate insiders own 29.57% of the company’s stock.
Web*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; WebMar 1, 2024 · Shares Outstanding 220.26M Public Float 156.45M Beta N/A Rev. per Employee $286.02K P/E Ratio 24.96 EPS $0.83 Yield 2.71% Dividend $0.19 Ex-Dividend Date Aug 18, 2024 Short Interest N/A % of...
WebFeb 21, 2024 · Hikma Pharmaceuticals' estimated fair value is UK£21.03 based on 2 Stage Free Cash Flow to Equity With UK£17.69 share price, Hikma Pharmaceuticals appears to be trading close to its estimated fair value Our fair value estimate is 8.3% lower than Hikma Pharmaceuticals' analyst price target of US$19.28 WebMar 14, 2024 · A Look At Hikma Pharmaceuticals' Liabilities. According to the last reported balance sheet, Hikma Pharmaceuticals had liabilities of US$1.08b due within 12 months, and liabilities of US$1.25b due beyond 12 months. Offsetting this, it had US$270.0m in cash and US$841.0m in receivables that were due within 12 months.
WebApr 12, 2024 · Hikma Pharmaceuticals - HKMPY Stock Forecast, Price & News $41.31 0.00 (0.00%) (As of 03/20/2024 12:00 AM ET) Compare Today's Range $41.31 $41.31 50-Day Range $40.43 $43.77 52-Week Range $25.12 $58.01 Volume 182 shs Average Volume 1,788 shs Market Capitalization N/A P/E Ratio 13.35 Dividend Yield 0.77% Price Target N/A …
WebApr 14, 2024 · In other Hikma Pharmaceuticals news, insider Deneen Vojta purchased 1,000 shares of the firm’s stock in a transaction on Tuesday, January 17th. The shares were … magic hohmannWebMar 1, 2024 · Shares Outstanding 220.26M Public Float 156.45M Beta N/A Rev. per Employee $286.02K P/E Ratio 24.96 EPS $0.83 Yield 2.71% Dividend $0.19 Ex-Dividend … magichole.gaWeb(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker. Hikma launches... magic holder broom \u0026 mop organizerWebApr 12, 2024 · Inside information, Press Release. London, 12 April 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has been appointed Chief Executive Officer (CEO), effective 1 September 2024. Thereafter, Said Darwazah will step down as acting CEO and return to … magichold monitor standWebInformation and tools including share price information, dividends, and the latest reports, results and news. Visit this section Investors magichole gaWebApr 3, 2024 · Get the latest up-to-the minute news on Hikma Pharmaceuticals from ADVFN. 12/04/2024 09:53:20 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Monitor; Quote; Charts; Trades; News; ... Share Description; Hikma Pharmaceuticals Plc: LSE:HIK: London: Ordinary Share: GB00B0LCW083: ORD SHS 10P Price Change % Change Share … magic holdings international ltdWebStock analysis for Hikma Pharmaceuticals PLC (HIK:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. magichold parts